🥇 First rule of investing? Know when to save! Up to 55% off InvestingPro before BLACK FRIDAYCLAIM SALE

Japan stocks end higher on gains in drugmakers, tech stocks

Published 2020/12/23, 08:59
Updated 2020/12/23, 09:00
© Reuters.
JP225
-
AAPL
-
IXIC
-
TOPX
-
7267
-
4568
-
9984
-
6861
-
ICOMS.T
-
IELEC.T
-
IPHAM.T
-

By Stanley White

TOKYO, Dec 23 (Reuters) - Japanese stocks ended higher on Wednesday as investors bet the healthcare sector would continue to benefit from a prolonged battle with the coronavirus, while technology shares rose on signs that Apple was eying an entry into electric cars.

The Nikkei 225 Index .N225 rose 0.33% to 26,524.79, while the broader Topix .TOPX rose 0.23% to 1,765.21.

Pharmaceuticals .IPHAM.T rose 0.9% on hopes for better earnings after Mizuho Securities raised its price target for Daiichi Sankyo Co Ltd 4568.T and as the spread of a more contagious COVID-19 strain in Britain sparked expectations of longer battle with virus.

The healthcare sector has benefited from the pandemic due to increased demand for treatments, although the virus outbreak's broader impact on the global economy has kept investors on edge.

"People are buying (those) stocks on dips that they expect to lead growth as they try to anticipate what will happen next year," a dealer at a domestic broker said.

Electronic parts makers .IELEC.T and information and communications stocks .ICOMS.T rose 0.8% and 0.03%, respectively, tracking a record close for the Nasdaq .IXIC on signs that Apple Inc AAPL.O was moving ahead with the production of electric vehicles. gainers among the top 30 core Topix names were Daiichi Sankyo Co Ltd 4568.T and Keyence Corp 6861.T , rising 2.9% and 1.9%, respectively.

However, financials fell, showing lingering caution.

The underperformers among the Topix 30 were SoftBank Group Corp 9984.T down 2.56%, followed by Honda Motor Co Ltd 7267.T losing 2.33%.

Japanese automakers took a hit after a local media report that the government would set a goal of banning new sales of gasoline-powered cars by the mid 2030s.

There were 80 advancers on the Nikkei index against 141 decliners.

The volume of shares traded on the Tokyo Stock Exchange's main board .TOPX was 0.89 billion, compared to the average of 1.33 billion in the past 30 days.

Latest comments

Risk Disclosure: Trading in financial instruments and/or cryptocurrencies involves high risks including the risk of losing some, or all, of your investment amount, and may not be suitable for all investors. Prices of cryptocurrencies are extremely volatile and may be affected by external factors such as financial, regulatory or political events. Trading on margin increases the financial risks.
Before deciding to trade in financial instrument or cryptocurrencies you should be fully informed of the risks and costs associated with trading the financial markets, carefully consider your investment objectives, level of experience, and risk appetite, and seek professional advice where needed.
Fusion Media would like to remind you that the data contained in this website is not necessarily real-time nor accurate. The data and prices on the website are not necessarily provided by any market or exchange, but may be provided by market makers, and so prices may not be accurate and may differ from the actual price at any given market, meaning prices are indicative and not appropriate for trading purposes. Fusion Media and any provider of the data contained in this website will not accept liability for any loss or damage as a result of your trading, or your reliance on the information contained within this website.
It is prohibited to use, store, reproduce, display, modify, transmit or distribute the data contained in this website without the explicit prior written permission of Fusion Media and/or the data provider. All intellectual property rights are reserved by the providers and/or the exchange providing the data contained in this website.
Fusion Media may be compensated by the advertisers that appear on the website, based on your interaction with the advertisements or advertisers.
© 2007-2024 - Fusion Media Limited. All Rights Reserved.